Literature DB >> 10803880

CD27/CD70 interactions regulate T dependent B cell differentiation.

S Jacquot1.   

Abstract

CD27 is a tumor necrosis factor (TNF) receptor family member whose expression is limited to cells of the lymphoid lineage. Constitutively expressed on T lymphocytes, it is a costimulatory molecule for a regulatory subset. Induced on B lymphocytes after antigenic challenge, it is a marker of memory cells. CD70, CD27 ligand, is a TNF related trans-membrane protein induced upon activation on T and B cells. In complement of ligation of CD40, another TNF receptor family member expressed by B cells, CD27/CD70 interaction plays a key role in T dependent B cell responses and is responsible for plasma cell differentiation. B lymphocyte responses appear thus controlled by different T cell subsets expressing CD154 (CD40 ligand), CD27, or CD70 (CD27 ligand).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10803880     DOI: 10.1385/IR:21:1:23

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  51 in total

1.  Generation of memory B cells and plasma cells in vitro.

Authors:  C Arpin; J Déchanet; C Van Kooten; P Merville; G Grouard; F Brière; J Banchereau; Y J Liu
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

2.  CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein.

Authors:  K V Prasad; Z Ao; Y Yoon; M X Wu; M Rizk; S Jacquot; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

3.  Antigen presentation by memory B cells: the sting is in the tail.

Authors:  D Tarlinton
Journal:  Science       Date:  1997-04-18       Impact factor: 47.728

4.  Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen.

Authors:  R A van Lier; J Borst; T M Vroom; H Klein; P Van Mourik; W P Zeijlemaker; C J Melief
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

5.  CD27-CD70 interactions regulate B-cell activation by T cells.

Authors:  T Kobata; S Jacquot; S Kozlowski; K Agematsu; S F Schlossman; C Morimoto
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

6.  CD27 is a signal-transducing molecule involved in CD45RA+ naive T cell costimulation.

Authors:  T Kobata; K Agematsu; J Kameoka; S F Schlossman; C Morimoto
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

7.  CD70 represents the human ligand for CD27.

Authors:  R Q Hintzen; S M Lens; G Koopman; S T Pals; H Spits; R A van Lier
Journal:  Int Immunol       Date:  1994-03       Impact factor: 4.823

8.  CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions.

Authors:  K Sugita; T Hirose; D M Rothstein; C Donahue; S F Schlossman; C Morimoto
Journal:  J Immunol       Date:  1992-11-15       Impact factor: 5.422

9.  Characterization of the human CD27 ligand, a novel member of the TNF gene family.

Authors:  R Q Hintzen; S M Lens; M P Beckmann; R G Goodwin; D Lynch; R A van Lier
Journal:  J Immunol       Date:  1994-02-15       Impact factor: 5.422

10.  Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor.

Authors:  R G Goodwin; M R Alderson; C A Smith; R J Armitage; T VandenBos; R Jerzy; T W Tough; M A Schoenborn; T Davis-Smith; K Hennen
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

View more
  11 in total

Review 1.  All in the head: obstacles for immune rejection of brain tumours.

Authors:  Paul R Walker; Thomas Calzascia; Pierre-Yves Dietrich
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

Review 2.  The significance of non-T-cell pathways in graft rejection: implications for transplant tolerance.

Authors:  Xian Chang Li
Journal:  Transplantation       Date:  2010-11-27       Impact factor: 4.939

3.  Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation.

Authors:  Cornelia Gujer; Christopher Sundling; Robert A Seder; Gunilla B Karlsson Hedestam; Karin Loré
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

4.  Effect of HLA-G5 Immune Checkpoint Molecule on the Expression of ILT-2, CD27, and CD38 in Splenic B cells.

Authors:  Hana Rohn; Cordula Lang; Sabine Schramm; Falko M Heinemann; Mirko Trilling; Anja Gäckler; Oliver Witzke; Peter A Horn; Vera Rebmann
Journal:  J Immunol Res       Date:  2022-05-12       Impact factor: 4.493

Review 5.  CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies.

Authors:  Katsiaryna Marhelava; Marta Krawczyk; Malgorzata Firczuk; Klaudyna Fidyt
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

Review 6.  Antibody-Drug Conjugates for the Treatment of Hematological Malignancies: A Comprehensive Review.

Authors:  Cédric Rossi; Marie-Lorraine Chrétien; René-Olivier Casasnovas
Journal:  Target Oncol       Date:  2018-06       Impact factor: 4.493

7.  CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.

Authors:  Allen W Ho; Evdoxia Hatjiharissi; Bryan T Ciccarelli; Andrew R Branagan; Zachary R Hunter; Xavier Leleu; Olivier Tournilhac; Lian Xu; Kelly O'Connor; Robert J Manning; Daniel Ditzel Santos; Mariana Chemaly; Christopher J Patterson; Jacob D Soumerai; Nikhil C Munshi; Julie A McEarchern; Che-Leung Law; Iqbal S Grewal; Steven P Treon
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

Review 8.  Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.

Authors:  A C Foks; J Kuiper
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

Review 9.  The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis.

Authors:  Ricardo F Antunes; Juan Carlos Kaski; Ingrid E Dumitriu
Journal:  J Biomed Biotechnol       Date:  2011-12-22

10.  Circulating B Cells With Memory and Antibody-Secreting Phenotypes Are Detectable in Pediatric Kidney Transplant Recipients Before the Development of Antibody-Mediated Rejection.

Authors:  Clara Fischman; Miguel Fribourg; Ginevri Fabrizio; Michela Cioni; Patrizia Comoli; Arcangelo Nocera; Massimo Cardillo; Chiara Cantarelli; Lorenzo Gallon; Astgik Petrosyan; Stefano Da Sacco; Laura Perin; Paolo Cravedi
Journal:  Transplant Direct       Date:  2019-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.